Nearly unanimous Merck (MRK) shareholders approve the company's $41.1B acquisition of...


Nearly unanimous Merck (MRK) shareholders approve the company's $41.1B acquisition of Schering-Plough (SGP), a move that would allow Merck to jump from eighth in prescription drug sales to second, behind Pfizer (PFE). The deal won 99% approval from voters; SGP shareholders vote later this afternoon.

From other sites
Comments (1)
  • Living4Dividends
    , contributor
    Comments (1210) | Send Message
     
    When Pfizer announced there takeover recently, they cut the dividend

     

    Did Merck also announce that they would be cutting the dividend?
    7 Aug 2009, 10:26 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs